Array cancer drug gets FDA's breakthrough therapy designation

Array cancer drug gets FDA's breakthrough therapy designation


Boulder-based pharmaceutical firm Array BioPharma Inc. has received the U.S. Food and Drug Administration's breakthrough therapy designation for an investigational drug combination to treat colorectal cancer, according to a company news release.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога